AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
AviadoBio's investors include New Enterprise Associates, F-Prime, EQT Life Sciences, Johnson & Johnson Innovation, Alzheimer's Drug Discovery Foundation.
AviadoBio is headquartered in London, United Kingdom.
AviadoBio transform the lives of people living with neurodegenerative disorders by developing and delivering transformative gene therapies
AviadoBio is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"AviadoBio — Funding & Investors." VCBacked, March 31, 2026, https://www.vcbacked.co/company/aviadobio. Accessed July 19, 2026.
VCBacked. (2026). AviadoBio — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/aviadobio
{{cite web |title=AviadoBio — Funding & Investors |url=https://www.vcbacked.co/company/aviadobio |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated